Intersect ENT, Inc. Payment for Contingent Consideration Liability, Financing Activities
Intersect ENT, Inc. reported Payment for Contingent Consideration Liability, Financing Activities of $20.29 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities · last filed 2022-03-08
- Intersect ENT, Inc. payment for contingent consideration liability, financing activities for fiscal 2021 was $20.29M.
- Intersect ENT, Inc. payment for contingent consideration liability, financing activities for fiscal 2020 was $0.00.
- Intersect ENT, Inc. payment for contingent consideration liability, financing activities for fiscal 2019 was $0.00.
| Period end | Payment for Contingent Consideration Liability, Financing Activities 12 month |
|---|---|
| 2021-12-31 | $20.29M 10-K · filed 2022-03-08 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-08 |
| 2019-12-31 | $0.00 10-K · filed 2022-03-08 |